We collect cookies for vital website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.
Article from 2019-08-28
Michael Miller, Samantha Goodwin, and Roxanne Franckowski
This application note was originally published in the July/August edition of Cannabis Science and Technology (PDF).
High-quality reference materials with established metrological traceability are an essential element for measurement accuracy during routine analytical checks as well as for Cannabis product quality testing and profiling. We compare two different methods using certified reference materials (CRMs) to generate a standard for the quantitation of ten prevalent phytocannabinoids against a calibration curve to show that pre-made multi-component CRM mixtures improve quantitation accuracy.
With the increased availability of Cannabis products, various stakeholders, such as the European Union, the UK's Food Standards Agency, and United States Pharmacopeia, are moving toward standardizing this growing industry as a way to protect consumers. As part of this standardization, many testing laboratories are strongly urged, if not required, to be ISO/IEC 17025 accredited. A key component for testing under an ISO/IEC 17025 quality system is the use of a Certified Reference Material (CRM) to maintain metrological traceability in its measurements.1 ISO 17034 commercially produced CRMs are ideal for quantitative analysis in the Cannabis testing industry. A CRM’s certificate of analysis will include a statement of metrological traceability as well as the certified concentration and the measurement of uncertainty associated with the material.
Historically, single analyte CRMs have been the default option for quality control testing, mainly due to the lack of availability of multi-component CRMs. Now that multi-component CRMs are available, they provide an advantage in many applications. For instance, when evaluating several analytes at once, a commercially formulated multi-component CRM bypasses the additional steps an analyst must take to create a stock solution from single CRMs. The data provided in this application note compares a typical method for preparing stock solutions from several single-component CRMs (Method A) against the use of a pre-made multi-component CRM (Method B).
Mixtures created from each of these methods were injected on the Cannabis Analyzer for Potency™ HPLC model LC-2030C Plus from Shimadzu Scientific Instruments. Concentrations of and 100 µg/ml were analyzed against the weighted calibration curve to evaluate differences between the two methods. For brevity, the 100 µg/ml results are discussed in the full application note. Accuracy of the mixtures was determined by comparing the experimental concentrations to the theoretical concentrations of each component.
The calibration curve was developed using Cayman’s Phytocannabinoid Mixture 10 (CRM) in accordance with the “Cannabis Analyzer for Potency™ Quick Guide” provided by Shimadzu.2 This mixture, in acetonitrile, contains 250 µg/ml of each of the following: cannabidivarin (CBDV), cannabidiolic acid (CBDA), cannabigerolic acid (CBGA), cannabigerol (CBG), cannabidiol (CBD), cannabinol (CBN), tetrahydrocannabinolic acid A (THCA-A), Δ9-tetrahydrocannabinol (Δ9-THC), Δ8-tetrahydrocannabinol (Δ8-THC), and (±)-cannabichromene (CBC). The High-Resolution Method from Shimadzu was used in the analysis of this calibration curve.3 A linear dynamic range of 0.5 to 250 µg/ml was established for each of the ten analytes in the Phytocannabinoid Mixture 10 (CRM). A weighted regression curve of 1/[X]2 was generated for each compound to provide a relative representation of concentration at both the low and high ends of the curve.
For Method A, a stock solution containing ten single component CRMs (each at 1 mg/ml in 1 ml of either acetonitrile or methanol) was prepared by pouring each of the single CRMs into separate HPLC vials. Then, 1 ml of each individual CRM compound was pipetted into a 25 ml scintillation vial to create a mixture at a concentration of 100 µg/ml. For Method B, an independent batch of Cayman’s pre-made Phytocannabinoid Mixture 10 (CRM) served as the commercially formulated multi-component CRM. This was poured into a separate HPLC vial, then a 400 µl aliquot was transferred to a 1 ml volumetric flask and brought to volume with methanol to create the 100 µg/ml solution. On two separate days, eight solutions were prepared by two separate analysts using each method.
For both methods, a single injection of each solution (n = 8) was analyzed, generating a total of 16 injections. Two samples, one each from Method A and Method B, were analyzed on a separate day than the other 14 samples. The experimental concentration for each component was derived from the calibration curve. These concentrations were averaged across all injections for each component, plotted with their respective standard deviations, and compared to the theoretical concentrations (Figure 1). The theoretical concentrations were calculated based on the certified concentrations from the certificates of analysis.
Figure 1. Experimental concentration at 100 µg/ml of Method A and Method B solutions compared to respective theoretical concentrations.
The accuracy, relative error, and precision results were tabulated for each compound (Table I). The accuracy and relative error of the experimental concentrations for each of the sample components were calculated against the respective theoretical concentrations. Greater deviation of the concentrations was observed with the Method A solution than with the Method B solution. Some variations in both Methods A and B may be attributed to the loss of solution during the transfer of the CRM to the larger HPLC vial, which could alter the concentration. A relative error of ±10% of the verified concentration is an acceptable criterion in analytical testing.4 Using this value, the calculated relative error for both Method A and Method B meet this criterion. We defined precision as the coefficient of variation in percent form. As shown in Table I, the precision observed by Method B is better across all components compared to Method A.
| Table I: Accuracy, Relative Error, and Precision (n = 8) | ||||||
| 100 µg/ml | Accuracy (%) | Relative Error (%) | Precision (CV, %) | |||
| Compound | Method A | Method B | Method A | Method B | Method A | Method B |
| CBDV | 102.77 | 97.14 | 2.77 | -2.86 | 3.72 | 0.60 |
| CBDA | 98.71 | 99.10 | -1.29 | -0.90 | 7.14 | 0.63 |
| CBGA | 104.94 | 98.24 | 4.94 | -1.76 | 3.58 | 0.66 |
| CBG | 101.42 | 96.55 | 1.42 | -3.45 | 5.44 | 0.64 |
| CBD | 97.72 | 95.32 | -2.28 | -4.68 | 1.49 | 0.61 |
| CBN | 105.31 | 101.43 | 5.31 | 1.43 | 2.99 | 0.62 |
| THCA-A | 103.45 | 99.21 | 3.45 | -0.79 | 2.53 | 0.64 |
| Δ9-THC | 98.24 | 98.40 | -1.76 | -1.60 | 4.80 | 0.61 |
| Δ8-THC | 103.40 | 100.46 | 3.40 | 0.46 | 2.85 | 0.58 |
| CBC | 100.52 | 100.02 | 0.52 | 0.02 | 2.64 | 0.64 |
There are multiple approaches to create working solutions of a phytocannabinoid mixture. Complications can arise when preparing a stock standard using single-component CRMs. All CRM materials used in this experiment were produced under an ISO 17034 quality system and, therefore, had metrologically traceable concentrations before the ampules were opened. The variability observed in the experimental concentrations of the Method A solution was likely related to the preparation of the stock solution. The multiple pipetting steps required to prepare the mixture may have affected the actual concentration of the stock solution. Furthermore, each preparation event, such as pipetting, adds uncertainty to the reported value and may also compromise the metrological traceability of the concentration when each component is removed from its original container and added to the mixture.
While the approach utilized in Method A is a seemingly practical method seen in industry standards, inconsistencies in reported concentrations were noted across multiple injections in our experiment. The commercially prepared CRM mixture was shown to improve precision and accuracy of the analysis. When used with proper methodology and optimized procedures, ISO 17034-produced multi-component CRM mixtures are designed to give the user confidence in their analytical data, mitigating regulatory related risks. They also offer a simpler approach, saving time, effort, and cost.
1. International Standard ISO/IEC 17025. General requirements for the competence of testing and calibration laboratories. (2017).
2. Shimadzu. Cannabis analyzer for potency quick guide. (2018).
3. Shimadzu. Potency testing in cannabis extracts using a high-resolution method with the cannabis analyzer for potency. (2017).
4. DeSilva, B., Smith, W., Weiner, R., et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm. Res. 20(11), 1885-1900 (2003).
Cayman offers a suite of ISO 17034-produced CRM mixtures designed and engineered to the highest standards to give you confidence in your analytical data. While offering simplicity in its use, these materials provide highly accurate and precise data when used with proper methodology.
| Item No. | Single CRMs included | 1 mg/ml each | 500 μg/ml each | 500 μg/ml each | 250 μg/ml each | 250 μg/ml each |
| ISO60156 | Cannabidiol (CRM) | |||||
| ISO60183 | Cannabinol (CRM) | |||||
| ISO60157 | Δ9-THC (CRM) | |||||
| 18090 | Cannabidiolic Acid (CRM) | |||||
| ISO60175 | THCA-A (CRM) | | ||||
| 20164 | Cannabigerol (CRM) | | ||||
| ISO60163 | (±)-Cannabichromene (CRM) | |||||
| 20165 | Cannabidivarin (CRM) | |||||
| 20019 | Cannabigerolic Acid (CRM) | |||||
| ISO60158 | Δ8-THC (CRM) | |||||
| 18091 | Tetrahydrocannabivarin |
Cayman Chemical
About UsManagement TeamCareersBuy Cayman GearIntellectual Property ProgramsContact UsConferences
Conference ScheduleContact Info
Cayman Chemical1180 East Ellsworth RoadAnn Arbor, Michigan 48108 USA